News + Filings Holdings
All
13F
13D/G
Other
|
|
PFM Health Sciences, LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/21/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/17/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/10/2022 |
SC 13G
| PFM Health Sciences, LP reports a 8.7% stake in ESSA Pharma, Inc. |
| 10/24/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/17/2022 |
SC 13G
| PFM Health Sciences, LP reports a 5.5% stake in Arcus Biosciences, Inc. |
| 09/06/2022 |
SC 13G
| PFM Health Sciences, LP reports a 6.3% stake in Erasca, Inc. |
| 09/06/2022 |
SC 13G
| PFM Health Sciences, LP reports a 5.1% stake in Generation Bio Co. |
| 07/18/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/17/2022 |
SC 13G
| PFM Health Sciences, LP reports a 5.4% stake in Praxis Precision Medicines, Inc. |
| 05/09/2022 |
SC 13G
| PFM Health Sciences, LP reports a 5.8% stake in Adaptimmune Therapeutics PLC |
| 05/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/25/2022 |
SC 13G
| PFM Health Sciences, LP reports a 5.2% stake in IO Biotech, Inc. |
| 02/07/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/06/2021 |
SC 13G
| PFM Health Sciences, LP reports a 7.2% stake in Caribou Biosciences, Inc. |
| 02/01/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/09/2020 |
SC 13G
| PFM Health Sciences, LP reports a 5.2% stake in Arcus Biosciences, Inc. |
| 09/25/2020 |
SC 13G
| Partner Fund Management, L.P. reports a 6.8% stake in Outset Medical, Inc. |
| 04/05/2019 |
SC 13G
| Partner Fund Management, L.P. reports a 6.1% stake in Dermira, Inc. |
| 04/01/2019 |
SC 13G
| Partner Fund Management, L.P. reports a 6% stake in Voyager Therapeutics, Inc. |
| 03/18/2019 |
SC 13G
| Partner Fund Management, L.P. reports a 6.8% stake in Puma Biotechnology, Inc. |
| 02/04/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/28/2018 |
SC 13G
| Partner Fund Management, L.P. reports a 5.9% stake in Spark Therapeutics, Inc. |
| 10/29/2018 |
SC 13G
| Partner Fund Management, L.P. reports a 6.1% stake in Audentes Therapeutics, Inc. |
| 10/22/2018 |
SC 13G
| Partner Fund Management, L.P. reports a 7.2% stake in Equillium, Inc. |
| 08/27/2018 |
SC 13G
| Partner Fund Management, L.P. reports a 5.2% stake in Arena Pharmaceuticals, Inc. |
| 08/06/2018 |
SC 13G
| Partner Fund Management, L.P. reports a 5.4% stake in Aptinyx Inc. |
| 07/13/2018 |
SC 13G
| Partner Fund Management, L.P. reports a 5.1% stake in Myokardia, Inc. |
| 07/09/2018 |
SC 13G
| Partner Fund Management, L.P. reports a 6.4% stake in Neon Therapeutics, Inc. |
| 06/21/2018 |
SC 13G
| Partner Fund Management, L.P. reports a 7.1% stake in Clovis Oncology, Inc. |
| 05/14/2018 |
SC 13G
| Partner Fund Management, L.P. reports a 9.3% stake in Esperion Therapeutics, Inc. |
| 04/16/2018 |
SC 13G
| Partner Fund Management, L.P. reports a 6% stake in Pacira Pharmaceuticals, Inc. |
| 02/12/2018 |
SC 13G
| Partner Fund Management, L.P. reports a 5.8% stake in Puma Biotechnology, Inc. |
| 11/16/2017 |
SC 13G
| Partner Fund Management, L.P. reports a 6.6% stake in Endocyte, Inc. |
| 11/13/2017 |
SC 13G
| Partner Fund Management, L.P. reports a 5.1% stake in Cutera, Inc. |
|
|
|